Aphidicolin inhibits the synthesis and joining of short DNA fragments but not the union of 10-kilobase DNA replication intermediates.
AUTOR(ES)
Lönn, U
RESUMO
DNA replication intermediates in human melanoma cells have been investigated by using the drug aphidicolin, which inhibits DNA polymerase alpha. In untreated cells, Okazaki fragments and 10-kilobase (kb) DNA intermediates are formed. In aphidicolin-treated cells, the replication fork is stopped and there is no formation of DNA replication intermediates. However, 10-kb DNA intermediates formed before the drug blockade are ligated to high molecular weight DNA whereas already formed Okazaki fragments accumulate in the cell. Moreover, in cells released from aphidicolin inhibition there is preferential labeling of 10-kb DNA compared to Okazaki fragments. The 10-kb DNA and the Okazaki fragments, therefore, respond differently to aphidicolin.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=394186Documentos Relacionados
- Accumulation of 10-kilobase DNA replication intermediates in cells treated with 3-aminobenzamide.
- There exists a distinct stage during mammalian DNA synthesis immediately after joining of replication intermediates.
- Inhibition of DNA synthesis by aphidicolin induces supercoiling in simian virus 40 replicative intermediates.
- A general method for the synthesis of 5'-monophosphates of DNA fragments via phosphotriester intermediates.
- Synthesis of DNA via deoxynucleoside H-phosphonate intermediates.
